Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
The S&P/TSX Composite Index fell 10 points on Tuesday, August 23. Canadian investors undoubtedly have a lot of questions on their mind, as this eventful summer winds to a close. Today, I want to focus on three things investors may want to watch for on the Toronto Stock Exchange (T...
The U.S. IPO market is ice cold following a hot 2021. One May IPO, Bausch + Lomb, is a household name with high uncertainty regarding a planned spinoff and a key drug. While shares trade at a reasonable valuation, the technical chart leaves much to be desired by the bulls. ...
Bausch Health Continuing Process Toward Separating Bausch + Lomb PR Newswire LAVAL, QC , Aug. 22, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") has transferred common shares in an amount equal to appr...
Some of the best growth stocks out there over the last few years are now on sale. And I mean a huge sale. Like, bargain-basement, how-low-can-this-go sale prices. In fact, some of the best ones remain priced not just at a discount, but under $20 per share. And this is a major point ...
Hedge fund Paulson & Co. exited its stake in oil major Exxon Mobil ( NYSE: XOM ) in Q2 and pared its existing holding in Occidental Petroleum ( NYSE: OXY ) by nearly 20%, according to its latest 13F filing . The fund, created and led by U.S. billionaire Joh...
In its recent 13-F filing , Larry Robbins and Mark Horowitz owned fund Glenview Capital indicated that it has acquired new stakes in Microsoft ( MSFT ) with 0.2M shares, Willis Towers Watson ( WTW ) with 0.13M shares, ZoomInfo Technologies ( ZI ) with 0.3M shares...
There is a clear and distinct trend throughout the history of stock investing slowly moving away from the professional money managers into the hands of the everyday man. Long before the rise and popularization of social media, it was finance and investment television shows that played...
Bausch Health Companies ( NYSE: BHC ) is appealing a federal court decision handed down Wednesday that declared several patents related to its drug Xifaxan (rifaximin) invalid. The U.S. District Court of Delaware found that patents related to the drug's composition and...
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit PR Newswire LAVAL, Quebec , Aug. 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmace...
The S&P/TSX Composite Index dropped 90 points on Tuesday, August 9. Most sectors finished the day in the red, and those that did not were only able to deliver marginal gains. It is still a challenging environment for investors in the late-summer season. Today, I want to discuss what...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
Stocks sold off Wednesday, weighed down by underwhelming reports from two mega-cap tech companies, leading to the S&P 500 and the NASDAQ Composite to post their worst session since 2022. The Dow Jones Industrials withered 504.22 points, or 1.3%, to 39,853.87. The much-broader index su...
A look at the top 10 most actives in Canada WildBrain Ltd. 5.875% Convertible Unsecured Subordinated Debentures (WILD.DB) rose 3.9% to $99.71 on volume of 19,212,000 shares Royal Bank of Canada (RY) fell 0.0% to $152.21 on volume of 13,856,076 shares Red Pine Exploration Inc. (RPX) fell 6...
LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources. The article contains unsubstantiated rumors, including that the Company is considering a bankruptcy o...